D-0771-2016 Class I Terminated

Recalled by Tf Supplements — Houston, TX

FDA drug recall D-0771-2016 was initiated by Tf Supplements on September 25, 2015 and is designated Class I. Reason for recall: Marketed without an Approved NDA/ANDA: Products contain undeclared desmethyl carbondenafil and dapoxetine. The recall status is terminated (terminated May 19, 2022). Affected quantity: 350 Bottles.

Recall Details

Product Type
Drugs
Report Date
March 16, 2016
Initiation Date
September 25, 2015
Termination Date
May 19, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
350 Bottles

Product Description

RHINO 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA

Reason for Recall

Marketed without an Approved NDA/ANDA: Products contain undeclared desmethyl carbondenafil and dapoxetine.

Distribution Pattern

Nationwide

Code Information

All lots